Omaha, NENCT04222062Now EnrollingIRB Ready

Metastatic Brain Disease Clinical Trial in Omaha, NE

Access cutting-edge metastatic brain disease treatment through this clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.

Sponsored by University of Nebraska

Quick Self-Assessment

See if you qualify for this Omaha location

Preparing your pre-screening questions...

Expert Care in Omaha

Access metastatic brain disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related metastatic brain disease treatment provided free

Apply for This Omaha Location

Check if you qualify for this metastatic brain disease clinical trial in Omaha, NE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Omaha

    Convenient for NE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Omaha site if eligible
  4. 4Begin participation

About This Metastatic Brain Disease Study in Omaha

This study is being done to see if adding GLIADEL to the site where the tumor was removed works as well as just having the tumor removed with radiation treatment done within six weeks after the surgery to keep the cancer from coming back.

Sponsor: University of Nebraska

Who Can Participate

Inclusion Criteria

Age 18 years or older (in states with 18 as age of majority); Age 19 years or older in Nebraska (age of majority)
Recursive partitioning analysis (RPA) class I, II or III with a Karnofsky Performance Status (KPS) of \>/ 60
Known or suspected primary solid cancer with metastatic brain tumor(s) - up to four in number and up to 4 cm in size with surgical resection planned for at least one site with Gliadel placement planned for only one site
Laboratory values adequate for patient to undergo surgery safely as determined by the attending neurosurgeon (transfusion permitted to reach goals)
Women of childbearing potential must have a negative pregnancy test within 7 days of initiating study. (No childbearing potential is defined as age 55 years or older and no menses for two years or any age with surgical removal of the uterus and/or both ovaries)
Normal coagulation studies (international normalized ratio, INR, ≤ 1.3)
Estimated survival time of ≥ 3 months (d

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Omaha?

Yes, this clinical trial (NCT04222062) has an active research site in Omaha, NE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Metastatic Brain Disease Treatment Options in Omaha, NE

If you're searching for metastatic brain disease treatment options in Omaha, NE, this clinical trial (NCT04222062) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Omaha research site is actively enrolling participants for this clinical trial. You'll receive care from experienced metastatic brain disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all metastatic brain disease clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Omaha, NE

See all essential tremor clinical trials recruiting in Omaha — not just this study.

Browse Essential Tremor Trials in Omaha →

Browse More Trials by Condition

Essential Tremor TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Omaha?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Omaha, NE